Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa

[cafead]

via Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday.

article source